Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia-Reference-Cited by-同舟云学术

Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia

Published:2010-02 Issue:2 Volume:29 Page:188-194
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Todd Nevins W.,Lavania Sachin,Park Myung H.,Iacono Aldo T.,Franks Teri J.,Galvin Jeffrey R.,Jeudy Jean,Britt Edward J.,Luzina Irina G.,Hasday Jeffrey D.,Atamas Sergei P.

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference21 articles.

1. Guidelines on diagnosis and treatment of pulmonary arterial hypertension;Galiè;Eur Heart J,2004

2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias;Am J Respir Crit Care Med,2002

3. Idiopathic pulmonary fibrosis: diagnosis and treatment;Am J Respir Crit Care Med,2000

4. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis;Lettieri;Chest,2006

5. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis;Nadrous;Chest,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review;BMJ Open Respiratory Research;2024-03

2. Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management;The Lancet Respiratory Medicine;2023-09

3. RSV‐induced LV dysfunction, what can be the underlying cause?;Pediatric Pulmonology;2022-12-28

4. Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension;Pulmonary Circulation;2022-07

5. Post-Mortem Metabolomics: A Novel Approach in Clinical Biomarker Discovery and a Potential Tool in Death Investigations;Chemical Research in Toxicology;2021-04-23